SuperGen to Webcast 5th Annual Investor & Analyst Day on April 12, 2011

SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, invites all interested parties to listen and view a live webcast of its 5th Annual Investor & Analyst Day from 8:30 a.m. to 12:00 p.m. ET on Tuesday, April 12, 2011.

During this event, SuperGen’s management team will provide updates on the Company’s clinical stage and discovery programs, including Dacogen® (decitabine) for Injection, amuvatinib (MP-470), SGI-110 and more.

Investors and interested parties may access the webcast in the Investor Events section of the Company's Web site at www.supergen.com. A webcast replay will be available for 90 days following the live event.

About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com.

Supergen, Inc. (MM) (NASDAQ:SUPG)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024